Search clinical trials for: Cardiovascular Physiological Phenomena

Total 154751 results

Stanford University
The Health Trust of Santa Clara County

Completed

Heart Disease on the Mend

Stroke | Hypertension | Coronary Heart Disease | Hyperlipidemia

United States
Catholic University of the Sacred Heart
Fondazione Telethon

Unknown

RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy

Myotonic Dystrophy | Sudden Cardiac Death

Italy
University Hospital, Saarland
Hoffmann-La Roche

Unknown

Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

Hepatitis C, Chronic
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

Carcinoma, Transitional Cell

France
Medical Benefits Fund of Australia

Completed

Evaluation of an Individualised Written Education Package for Stroke Patients

Stroke

Australia
East Valley Hematology and Oncology Medical Group
Astex Pharmaceuticals, Inc.; Pharmatech Oncology; Mena, Raul, M.D.

Unknown

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Chronic Lymphocytic Leukemia

United States
National Heart and Lung Institute
Wexham Park Hospital; 4th Military Hospital

Unknown

Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure

Heart Diseases | Anemia, Iron-Deficiency | Chronic Heart Failure

Poland, United Kingdom
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

AIDS Related Lymphoma

France
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Methadone/Buprenorphine Cross-Over Study - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression

HIV Infections

France
The Japanese Society of Hypertension

Unknown

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

Cardiovascular Diseases | Hypertension

Japan
Advanz Pharma

Completed

Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure

Congestive Heart Failure

United States
Royal Brompton & Harefield NHS Foundation Trust
British Heart Foundation

Completed

Programme to Optimise Risk Factors in Patients Waiting for Coronary Artery Bypass Surgery

Coronary Artery Disease

United Kingdom
Repligen Corporation

Completed

Synthetic Human Secretin in Children With Autism

Autism

United States
Makerere University
Ministry of Health, Uganda; Sanofi-Synthelabo

Unknown

Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria

Cerebral Malaria

Uganda
Heidelberg University
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation

Renal Failure | Heart Transplantation

Germany
French National Agency for Research on AIDS and...
Schering-Plough

Terminated

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Hepatitis C, Chronic

France
Khon Kaen University
National Research Council of Thailand

Completed

Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children

Bronchiolitis, Viral

Thailand
Erasmus Medical Center

Completed

A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer

Erectile Dysfunction | Prostate Cancer

Netherlands
Connor, Kathryn M., M.D.
Forest Laboratories

Completed

Study of Escitalopram in the Treatment of Specific Phobia

Phobic Disorders

United States
Oregon Health and Science University

Completed

4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions

Pain

United States
Anesiva, Inc.

Terminated

Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

Hyperplasia | Chronic Renal Failure

United States
Oregon Health and Science University

Completed

Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?

Breakthrough Bleeding

United States
University of Sydney
National Health and Medical Research Council, Australia; Sydney South West... and other collaborators

Unknown

Trial for the Treatment of Alcohol Dependence

Alcoholism

Australia
Anesiva, Inc.

Completed

Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures

Ischemia | Arterial Occlusive Diseases | Peripheral Vascular Diseases | Hyperplasia | Graft Occlusion, Vascular

United States, Canada
Min-Sheng General Hospital

Unknown

Effect of SACCHACHITIN on Healing of a Chronic Wound

Wounds

Taiwan
Sandoz

Completed

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

HIV Infections | Cytopenias

United States
Newport Pharmaceuticals International

Completed

A Study of Isoprinosine in Patients With Lymph Node Disease

HIV Infections | Lymphatic Disease

United States
Mucos Pharma GmbH and Co

Completed

The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

HIV Infections

United States
National Institute of Mental Health (NIMH)
Icahn School of Medicine at Mount Sinai

Completed

Study of Fluoxetine in Patients With Depersonalization Disorder

Depersonalization Disorder

United States
Immunobiology Research Institute

Completed

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

HIV Infections

United States, Puerto Rico
Corixa Corporation
GlaxoSmithKline

Unknown

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United Kingdom, United States
G D Searle

Completed

Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3

HIV Infections

United States
Otsuka America Pharmaceutical

Completed

A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons

HIV Infections

United States
Eunice Kennedy Shriver National Institute of Child...

Unknown

Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome

MELAS Syndrome

United States
National Center for Research Resources (NCRR)
James Whitcomb Riley Hospital for Children

Completed

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Thrombocytopenia | Dyskeratosis Congenita | Fanconi's Anemia | Shwachman Syndrome
G D Searle

Completed

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

HIV Infections

United States
Icahn School of Medicine at Mount Sinai

Completed

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

Syncope

United States
Fred Hutchinson Cancer Center
Facet Biotech

Unknown

Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

Graft-vs-Host Disease

United States
Immunobiology Research Institute

Completed

Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients

HIV Infections

United States
National Center for Research Resources (NCRR)
Indiana University School of Medicine

Completed

Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis

Cystic Fibrosis

Search clinical trials for: Cardiovascular Physiological Phenomena

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations